Ameritas Investment Partners’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Ameritas Investment Partners’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3	Closed	-$21K	–	3238
2021 Q1	$21K	Hold	3	–	–	﹤0.01%	2543
2020 Q4	$15K	Hold	3	–	–	﹤0.01%	2626
2020 Q3	$16K	Hold	3	–	–	﹤0.01%	2504
2020 Q2	$16K	Buy	3 +2	+200%	+$13.5K	﹤0.01%	2478
2020 Q1	$11K	Buy	+1	New	+$15.7K	﹤0.01%	2517
2019 Q4	–	Hold	0	–	–	–	2955
2019 Q3	–	Hold	0	–	–	–	3036
2019 Q2	–	Hold	0	–	–	–	2999
2019 Q1	–	Hold	0	–	–	–	2890
2018 Q4	–	Hold	0	–	–	–	2962
2018 Q3	–	Hold	0	–	–	–	2954
2018 Q2	–	Hold	0	–	–	–	2958
2018 Q1	–	Hold	0	–	–	–	2425

Other funds holding YARW

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Ameritas Investment Partners's YARW Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q2 2021, closing a stake of 3 shares — an estimated $21K sold.

Ameritas Investment Partners first reported a position in YARW in Q1 2020 and held it in 5 quarters. The position peaked at $21K in Q1 2021. 63 funds tracked by Wall St. Rank hold YARW as of Q2 2021.

Ameritas Investment Partners reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 3 Yarrow Bioscience, Inc. Common Stock shares in Q2 2021, an estimated $21K.
Ameritas Investment Partners first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2020 and held it in 5 quarters.
Ameritas Investment Partners's Yarrow Bioscience, Inc. Common Stock position peaked at $21K in Q1 2021.
63 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.